Skip to main content
Eisai to seek Chinese approval for liver cancer drug
7/5/2017

Eisai will seek approval from China for its new liver cancer drug Lenvima and plans to submit the drug for approval to Western countries this month. China is preparing to accept multiregional clinical data, which would significantly speed the approval process for new drugs.

Full Story: